Brazil tycoon Tanure to take control of Alliar -source
SAO PAULO, Nov 18 (Reuters) - Brazilian investor Nelson Tanure has reached a preliminary agreement with controlling shareholders in medical diagnostics company Alliar to take it over, a source familiar with the matter said on Thursday.
Tanure proposed to pay 20.50 reais ($3.69) per share, the source added, more than 65% above the previous day's closing price.
Alliar's controlling shareholders and Tanure are expected to conclude the deal in the coming days, the person said.
O Globo columnist Lauro Jardim reported the deal earlier on Thursday, sending Alliar's shares higher.
Tanure had previously offered 19 reais per share to take control of Centro de Imagem Diagnosticos SA, as the company is formally known, but the proposal was rejected by controlling shareholders in late October.
Shares in Alliar soared on the report, which led to a brief halt in trading of the stock in early morning in Sao Paulo. After a share auction process, the stock resumed trading, up about 15% at 14.29 reais.
Alliar and Tanure did not immediately respond to Reuters requests for comment.
Tanure disclosed an initial investment of 26% in Alliar in August, when Rede D'Or was in talks with the company's shareholders to take it over. Later, medical lab company Fleury also joined the race for Alliar.
The source did not disclose Tanure's stake in the company after the deal conclusion.
($1 = 5.5528 reais) (Reporting by Carolina Mandl and Gabriel Araujo; Editing by Emelia Sithole-Matarise and Steve Orlofsky)
